Detalhe da pesquisa
1.
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
N Engl J Med;
385(25): e90, 2021 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34551224
2.
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
MMWR Morb Mortal Wkly Rep;
73(16): 377-381, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38662708
3.
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep;
73(4): 77-83, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38300853
4.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep;
73(12): 271-276, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38547037
5.
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.
J Infect Dis;
227(7): 907-916, 2023 04 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36723871
6.
Continued Increase of Erythromycin Nonsusceptibility and Clindamycin Nonsusceptibility Among Invasive Group A Streptococci Driven by Genomic Clusters, United States, 2018-2019.
Clin Infect Dis;
76(3): e1266-e1269, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35684991
7.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep;
72(24): 657-662, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37319020
8.
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep;
72(34): 920-925, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37616235
9.
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
MMWR Morb Mortal Wkly Rep;
72(7): 177-182, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36795625
10.
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
MMWR Morb Mortal Wkly Rep;
72(5): 119-124, 2023 02 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36730051
11.
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep;
72(41): 1115-1122, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37824423
12.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
MMWR Morb Mortal Wkly Rep;
72(42): 1140-1146, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37856366
13.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep;
72(33): 886-892, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37590187
14.
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.
MMWR Morb Mortal Wkly Rep;
72(39): 1057-1064, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37874864
15.
Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March-April 2021.
Clin Infect Dis;
75(Suppl 2): S155-S158, 2022 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35758873
16.
Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District-United States, December 2020-January 2021.
Clin Infect Dis;
74(2): 319-326, 2022 01 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33864375
17.
Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.
Emerg Infect Dis;
28(11): 2338-2341, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36170764
18.
Invasive Group A Streptococcal Penicillin Binding Protein 2× Variants Associated with Reduced Susceptibility to ß-Lactam Antibiotics in the United States, 2015-2021.
Antimicrob Agents Chemother;
66(9): e0080222, 2022 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35969070
19.
Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data - United States, 2019.
MMWR Morb Mortal Wkly Rep;
71(6): 202-205, 2022 Feb 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35143465
20.
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
MMWR Morb Mortal Wkly Rep;
71(31): 988-992, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35925807